Simpler Grants.gov #R44

NCI SBIR Phase IIB Bridge Awards for Cancer Technology Commercialization

This opportunity is a forecasted funding notice from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), targeting small businesses with cancer-relevant technologies. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Purpose: - Soliciting Small Business Innovation Research (SBIR) applications for Phase IIB Bridge Awards - Supports projects previously funded under SBIR or STTR Phase II awards from any Federal agency - Products/Services Requested: - No specific products, OEMs, or part numbers are mentioned - Focus is on advancing cancer-relevant technologies through additional funding - Projects may be at preclinical or clinical stages; clinical trials are optional - Unique/Notable Requirements: - Applicants must submit a Commercialization Plan - Third-party funding (from investors or strategic partners) must match or exceed the NCI funds requested - Emphasis on facilitating transition to commercialization through partnerships - No OEMs or vendors are specified in this notice

Description

The National Cancer Institute (NCI) plans to publish a Notice of Funding Opportunity (NOFO) to solicit Small Business Innovation Research (SBIR) applications from small business concerns seeking additional funding to advance cancer-relevant projects previously funded under SBIR or STTR Phase II awards. The NOFO aims to facilitate the transition of these projects to commercialization by promoting partnerships with third-party investors or strategic partners. Applicants must submit a Commercialization Plan detailing any secured or anticipated third-party funding, which should match or exceed the NCI funds requested. Proposed projects may address preclinical and/or clinical stages, with clinical trials optional.

View original listing